
Daewoong Pharmaceutical Secures Largest Export Contract for Nabota in Southeast Asia
Daewoong Pharmaceutical has signed its largest-ever export contract with a partner in Thailand, bolstering the presence of its botulinum toxin product, Nabota, in the Southeast Asian market. On June 19, Daewoong Pharmaceutical announced the signing of a …